Agalsidase alfa
Replagal (agalsidase alfa) is an enzyme pharmaceutical. Agalsidase alfa was first approved as Replagal on 2001-08-03. It has been approved in Europe to treat fabry disease.
| Trade Name | Replagal |
|---|---|
| Common Name | Agalsidase alfa |
| Indication | fabry disease |
| Drug Class | Enzymes |
